New Sickle Cell Treatment Safe for Patients, FDA Panel Says
A breakthrough genetic therapy that can potentially cure sickle cell disease is poised for approval by the FDA in December. The treatment, called exa-cel, received a positive critique of its safety from an important FDA advisory panel during a 7-hour meeting on Tuesday. Exa-cel is a gene-editing treatment that changes the body’s process for making…
